DK0553130T3 - Pyrrolidindionderivater - Google Patents
PyrrolidindionderivaterInfo
- Publication number
- DK0553130T3 DK0553130T3 DK91917487.0T DK91917487T DK0553130T3 DK 0553130 T3 DK0553130 T3 DK 0553130T3 DK 91917487 T DK91917487 T DK 91917487T DK 0553130 T3 DK0553130 T3 DK 0553130T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- relates
- compounds
- associated complications
- diabetes associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59761490A | 1990-10-15 | 1990-10-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0553130T3 true DK0553130T3 (da) | 1996-02-05 |
Family
ID=24392236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91917487.0T DK0553130T3 (da) | 1990-10-15 | 1991-09-13 | Pyrrolidindionderivater |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0553130B1 (de) |
JP (1) | JPH0692367B2 (de) |
AT (1) | ATE132486T1 (de) |
CA (1) | CA2091566A1 (de) |
DE (1) | DE69116162T2 (de) |
DK (1) | DK0553130T3 (de) |
ES (1) | ES2082232T3 (de) |
FI (1) | FI931666A (de) |
GR (1) | GR3018920T3 (de) |
IE (1) | IE913554A1 (de) |
PT (1) | PT99224A (de) |
WO (1) | WO1992006954A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL327445A1 (en) * | 1995-12-15 | 1998-12-07 | Novo Nordisk As | Novel process |
IL153278A0 (en) * | 2000-06-21 | 2003-07-06 | Hoffmann La Roche | Benzothiazole derivatives |
ATE550320T1 (de) | 2001-08-10 | 2012-04-15 | Shionogi & Co | Antivirales mittel |
CN104001078A (zh) * | 2014-06-05 | 2014-08-27 | 青岛市城阳区人民医院 | 一种治疗糖尿病肾病的中药药剂及制备方法 |
CN107892666B (zh) * | 2017-12-12 | 2021-10-15 | 吉林医药学院 | 一种5-苯基吡咯衍生物及其制备方法和用途 |
-
1991
- 1991-09-13 EP EP91917487A patent/EP0553130B1/de not_active Expired - Lifetime
- 1991-09-13 JP JP3516047A patent/JPH0692367B2/ja not_active Expired - Lifetime
- 1991-09-13 WO PCT/US1991/006483 patent/WO1992006954A2/en active IP Right Grant
- 1991-09-13 DE DE69116162T patent/DE69116162T2/de not_active Expired - Fee Related
- 1991-09-13 ES ES91917487T patent/ES2082232T3/es not_active Expired - Lifetime
- 1991-09-13 CA CA002091566A patent/CA2091566A1/en not_active Abandoned
- 1991-09-13 AT AT91917487T patent/ATE132486T1/de not_active IP Right Cessation
- 1991-09-13 DK DK91917487.0T patent/DK0553130T3/da active
- 1991-10-14 PT PT99224A patent/PT99224A/pt not_active Application Discontinuation
- 1991-10-16 IE IE355491A patent/IE913554A1/en unknown
-
1993
- 1993-04-14 FI FI931666A patent/FI931666A/fi not_active Application Discontinuation
-
1996
- 1996-02-07 GR GR960400326T patent/GR3018920T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH05507284A (ja) | 1993-10-21 |
EP0553130A1 (de) | 1993-08-04 |
IE913554A1 (en) | 1992-04-22 |
DE69116162D1 (de) | 1996-02-15 |
WO1992006954A3 (en) | 1992-08-06 |
PT99224A (pt) | 1992-09-30 |
JPH0692367B2 (ja) | 1994-11-16 |
DE69116162T2 (de) | 1996-05-02 |
WO1992006954A2 (en) | 1992-04-30 |
ATE132486T1 (de) | 1996-01-15 |
EP0553130B1 (de) | 1996-01-03 |
CA2091566A1 (en) | 1992-04-16 |
FI931666A0 (fi) | 1993-04-14 |
GR3018920T3 (en) | 1996-05-31 |
ES2082232T3 (es) | 1996-03-16 |
FI931666A (fi) | 1993-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69413542D1 (de) | Perhydroisoindolderivate als substanz p antagonisten | |
AU674477B2 (en) | Heterocyclic-cyclic amine derivatives | |
DK0468012T3 (da) | 17beta-substituerede 4-aza-5alfa-androstan-3-on-derivater og fremgangsmåde til fremstilling deraf | |
DE59401924D1 (de) | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel | |
SE8600174D0 (sv) | Nytt forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkylazaspiroalkandioner | |
FI101376B1 (fi) | Menetelmä 3-bentsyyliamino-2-fenyylipiperidiinijohdannaisten valmistamiseksi | |
FI962323A (fi) | N-substituoidut atsabisykloheptaanijohdannaiset, kuten esim. neuroleptit | |
DK0553130T3 (da) | Pyrrolidindionderivater | |
DE59109225D1 (de) | Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachter erkrankungen | |
FI970449A (fi) | N-substituoituja atsabisykloheptaanijohdannaisia, jotka ovat käyttökelpoisia neuroleptisinä aineina | |
ES2104174T3 (es) | Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos. | |
FI20021652A (fi) | Tratsodonin alkyylijohdannaisten valmistuksessa käyttökelpoisia välituotteita | |
ATE218138T1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung | |
HU9600300D0 (en) | Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these | |
ATE239015T1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung | |
FI944076A (fi) | Menetelmä terapeuttisesti käytt¦kelpoisten N-(3-hydroksi-4-piperidinyyli)(dihydrobentsofuraani-, dihydro-2H-bentsopyraani- tai dihydrobentsodioksiini)karboksamidijohdannaisten valmistamiseksi ja välituote | |
ATE263139T1 (de) | 3-alkoxylbenzylaminderivate und ihre verwendung als arzneimittel zur behandlung von schizophrenie |